“Cellular phenotyping and application of cytometry for diagnostics purposes” Part II Karolina Bukowska-Straková
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
“Cellular phenotyping and application of cytometry for diagnostics purposes”
Part II
Karolina Bukowska-Straková
Minimal Residual Disease – MRD
Most hematopoietic malignant cells resemble
normal lymphoid cells.
Yet, hematopoietic malignancies usually display aberrant or unusual antigen expression → detection of minimal residual disease (MRD) is still possible.
Multiparameter flow cytometry allows reliable detection of MRD in most lymphoid malignancies, thereby providing a better insight into treatment
effectiveness.
Aberrant immunophenotypes as targets for MRD detection
Aberrant or unusual immunophenotypes are the result of:- cross-lineage antigen expression, - maturational asynchronous expression of antigens,- antigen over- or under-expression, - the absence of antigen expression, - ectopic antigen expression
Aberrant immunophenotyp bringing the malignant blasts into the ‘empty spaces’ between normal lymphoid differentiation
Detection MRD is based on leukemia-specific immunophenotypes of malignant cells.
Day of diagnosis
33 day of treatment
1. Use muliticolour panel of mAbs (6≥mAbs) for optimal characteristics of leukemia-specific immunophenotypes
2. Select fluorochrome: - the brightest fluorochromes for weakly expressed antigens - the dim fluorochromes for strongly expressed antigens
3. Select best clone of mAbs
4. Take into consideration:- how rare are your cells- the sensitivity of FC
An approach to flow cytometric analysis of residual cells
Six-color panel
1) Syto16/-/CD19-APC/-/-/CD45-APC-H72) CD20-FITC/CD38-PE/CD34-PerCP-Cy5.5/CD10-PC7/CD19-APC/CD45-APC-H73) CD58-FITC/CD66c-PE/CD34-PerCP-Cy5.5/CD10-PC7/CD19-APC/CD45-APC-H7
Day of diagnosis
15 day of treatment
1. Use muliticolour panel of mAbs (6≥mAbs) for optimal characteristics of leukemia-specific immunophenotypes
2. Select fluorochrome: - the brightest fluorochromes for weakly expressed antigens - the dim fluorochromes for strongly expressed antigens
3. Select best clone of mAbs
4. Take into consideration:- how rare are your cells- the sensitivity of FC
An approach to flow cytometric analysis of residual cells
Optimal choice of fluorochromes according to the antigens and the flow cytometer
1. Use muliticolour panel of mAbs (6≥mAbs) for optimal characteristics of leukemia-specific immunophenotypes
2. Select fluorochrome: - the brightest fluorochromes for weakly expressed antigens - the dim fluorochromes for strongly expressed antigens
3. Select best clone of mAbs
4. Take into consideration:- how rare are your cells- the sensitivity of FC
An approach to flow cytometric analysis of residual cells
Choice of optimal clone of mAbs
José M. Casasnovas, Mykol Larvie and Thilo StehleThe EMBO Journal (1999) 18, 2911 - 2922
Compensation and calibration
The use of multiple fluorochromes requires an appropriate instrument set-up to compensate for spectral spillover.
In a standardized setting, with a calibrated flow cytometer and using the same mAbs clones, the staining patterns for all leukocyte subsets are stable
1. Use muliticolour panel of mAbs (6≥mAbs) for optimal characteristics of leukemia-specific immunophenotypes
2. Select fluorochrome: - the brightest fluorochromes for weakly expressed antigens - the dim fluorochromes for strongly expressed antigens
3. Select best clone of mAbs
4. Take into consideration:- how rare are your cells- the sensitivity of FC
An approach to flow cytometric analysis of residual cells
SENSITIVITY of FC10-3 - 10-4
(1 leukemic cell per 1.000 – 10.000)
At least 10-20 cells with leukemia-specific immunophenotype to be sure we see real cells
Positive MRD > 0,01% of BM cells
minimal number of cells to acquire 20 cells – 0,01%200.000 cells – 100%
yet, there are usually debris is sample (sometimes even more then 20%)
minimal number of events to collect > 300.000
Day of diagnosis
33 day of treatment
Day of diagnosis
ConclusionThe story of MRD is one of the most exciting examples of translational research, where basic research was transferred into high-technology laboratory diagnostics
International collaborative efforts ensure that all diagnostic MRD laboratories speak the same ‘MRD language’.
Flow-cytometric immunophenotyping is the sole technique that fulfils the requirements of high speed, broad applicability at diagnosis and during follow-up of immunological and hematological disorders with accurate focusing on the cell population of interest.
CBA(Cytometric Bead Array)
CBA(Cytometric Bead Array)
CBA(Cytometric Bead Array)
CBA(Cytometric Bead Array)
CBA(Cytometric Bead Array)
The CBA Human Soluble Protein Flex Set system provides several advantages when compared with conventional ELISA:
The CBA Human Soluble Protein Flex Set assays allow for multiplexed analysis of multiple proteins from a single sample
The CBA Human Soluble Protein Flex Set assays have a wider dynamic range than conventional ELISAs.
Lower amount of sample is needed.
Luminex system in our laboratory (FlexMap3D)
+Monensin
Surface Ag staining
Cytoplasmaticstaining
Cytoplamatic detection of cytokinesCytoplamatic detection of cytokines
Detection of Ag specific lymphocytes
using HLA-I pentamers
Cell sorting
Cell sorted MoFlo-XDP used in our laboratory
87%
3%
7%
99%
98%
84%
Magnetic cell sorting
1
2
3
AutoMacs used in our laboratory
Image Stream System – used in our laboratory
objective20x, 40x, 60x
ImageStream - applications
Stem cell analysisStem cell analysis
Co-localizataionCo-localizataion
Co-localization in cell subsets
Phagocytosis
Thank you for your attention =)
Related Documents
